VHB937: Clinical Trials

2 active not recruiting. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Active not recruiting 2

Follow VHB937: new trials by email Literature Review of VHB937 trials Research Report on VHB937

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease VHB937, Placebo - Alzheimer's Disease	Phase 2	Active not recruiting	Novartis Pharmaceuticals	97	2025-08-07	2026-10-21
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) VHB937, Placebo - Amyotrophic Lateral Sclerosis (ALS)	Phase 2	Active not recruiting	Novartis Pharmaceuticals	251	2024-10-17	2026-07-07

Conditions studied

Alzheimer Disease (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Dementia (1)  ·  Motor Neuron Disease (1)

Sponsors

Novartis Pharmaceuticals (2)

Countries

Australia (2)  ·  Canada (2)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Poland (2)  ·  South Korea (2)  ·  Spain (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Belgium (1)  ·  Czechia (1)